pharmaceutically acceptable carrier is active against the papilloma virus in both humans and animals the composition can be used to treat women suffering from cervical cancer the composition can also be used to treat cows and horses suffering sarcoids application_number US 90513510 A description the inventive composition comprises a content of a lysozyme the lysozyme can be naturally occurring synthetic or recombinant in principal all lysozymes are useful in the inventive composition although the intended use of the inventive composition may suggest to those skilled in the art a preference for one type of lysozyme as opposed to another in one preferred embodiment the lysozyme is a human recombinant lysozyme for example as is disclosed in u s pat no 6 991 824 the entire contents of which are hereby incorporated herein by reference in another preferred embodiment the lysozyme is a non human lysozyme especially a hen egg white lysozyme in a preferred embodiment the inventive composition additionally comprises at least one additional therapeutic agent effective against papilloma virus these additional therapeutic agents can be chemotherapeutic agents or other antiviral compounds the lytic activity of lysozyme on the virus envelop can be expected to improve the effectiveness of such additional therapeutic agents thus the inventive composition can further comprise an effective amount of one or more antiviral agents antiseptic agents chemotherapeutic agents immunopotentiating agents or mixtures thereof preferably the additional therapeutic agent is selected from the group consisting of acyclovir vidarabine uridine 5 fluorouracil thiotepa interferons podophyllotoxin trichloroacetic acid salicylic acid carbamide peroxide hexamethylene.